Roivant's Outstanding Achievement in Workplace Recognition
In a testament to its commitment to employee satisfaction and culture, Roivant (Nasdaq: ROIV) has been included in the Fortune magazine's prestigious 2025 Best Workplaces in BioPharma list. This remarkable recognition marks Roivant's debut on the list, securing the 28th position in the small & medium category. This achievement signifies Roivant as a standout choice for employment within the biopharma sector.
How the Rankings Were Determined
The ranking process for the Best Workplaces in BioPharma is rigorous and based on the feedback garnered from nearly 40,000 employees working at organizations certified by Great Place To Work. This esteemed accolade not only highlights Roivant's commitment to nurturing a positive work environment but also reinforces the company’s dedication to its workforce.
Leadership Insights on Receiving Recognition
Matt Gline, CEO of Roivant, commented on this honor, stating that the accolade reflects the company’s unwavering dedication to cultivating an empowering culture. He emphasized, "Our team's commitment to fostering a high-performance environment that nurtures talent is what makes Roivant a remarkable workplace. It is indeed our people who drive this success, and we are thrilled to celebrate this achievement together."
The Competitive Landscape of Biopharma Workplaces
Securing a position on the Best Workplaces in BioPharma list is no small feat. Great Place To Work employs its proprietary Trust Index™ Survey to assess and certify thousands of businesses across America, factoring in data from over 1.3 million survey responses. The selection process encompasses a detailed examination of workplace experiences, ensuring that the final list represents a true cross-section of employee sentiment.
Inclusivity and Diversity in the Selection Criteria
Notably, the honorees' selection criteria encompass a wide array of employee experiences, reflective of various job roles, racial backgrounds, genders, sexual orientations, and more. This inclusive approach ensures that companies earning recognition are truly committed to providing positive work experiences for all their employees.
About the !Fortune Best Workplaces in BioPharma
The methodology for the 2025 Fortune Best Workplaces in BioPharma was developed after analyzing over 1.3 million confidential employee surveys from 2024 and 2025. A significant portion of these insights was derived from employees working in companies recognized by Great Place To Work in the biopharmaceutical and biotechnology sectors. The ranking relies on constructive feedback driven by 60 critical employee experience questions.
Understanding Great Place To Work's Role
Great Place To Work has built a reputation as the global authority on workplace culture. With over 30 years of research and data, they strive to help organizations foster environments where every employee can thrive. Their platform, along with the Great Place To Work Model, evaluates workplace experiences, and exemplary organizations earn the coveted Great Place To Work Certification.
Engaging with Great Place To Work
For companies aspiring to join the ranks of great workplaces, engaging with Great Place To Work provides invaluable resources. Organizations receive guidance on how to assess and enhance workplace culture, with the ultimate goal of fostering a great environment for all employees.
About Roivant and Its Vision
Roivant, trading under the ticker symbol Nasdaq: ROIV, is more than just a biopharmaceutical company. It is committed to transforming patient lives by accelerating the development and commercialization of crucial medicines. The rich pipeline includes promising treatments like brepocitinib, aiming at various autoimmune conditions, alongside inhaled therapies for pulmonary hypertension.
By forming nimble subsidiaries known as “Vants,” Roivant continues to innovate in the fields of therapeutics and health technology, demonstrating flexibility in developing and capitalizing on their medicines and technologies.
In conclusion, Roivant's recent recognition on the 2025 Fortune Best Workplaces in BioPharma list is a milestone that highlights its accomplishments and its commitment to a positive work environment. As Roivant continues to grow and innovate, it remains focused on improving the lives of patients through its dedicated team and evolving healthcare solutions.
Frequently Asked Questions
What does being on the Fortune Best Workplaces list mean for Roivant?
This recognition signifies Roivant's strong commitment to employee satisfaction and workplace culture, establishing it as a desirable employer in the biopharma sector.
How are companies evaluated for the Best Workplaces in BioPharma?
Companies are assessed using the Trust Index™ Survey, which captures feedback from employees about their workplace experiences. Rankings are based on over 1.3 million survey responses.
What contributes to Roivant's workplace culture?
Roivant fosters an empowering culture that emphasizes high performance, innovation, and inclusivity, creating an environment where all employees can thrive.
What is the significance of the employee survey data?
The survey data provides comprehensive insights into workplace experiences and helps ensure that the Best Workplaces list accurately reflects employee sentiment across various demographics.
How does Roivant's mission align with its workplace recognition?
Roivant's mission to improve patient lives through innovative biopharmaceutical solutions is intrinsically linked to the satisfaction and engagement of its employees, who drive the company’s success.
